Therefore, the PI3K/AKT/mTOR pathway is involved in EMT-related pathways in cancer cells, controlling cytoskeletal reorganization, enhanced cellular motility, and tumor aggressiveness which are hallmarks of metastatic competence [20,65]. This evidence concerns the gene MTOR and neoplasm.